Abstract

Purpose: To evaluate the dosimetric accuracy of a novel CBCT estimation method using prior information for use in adaptive radiotherapy (ART)‐based treatment of lungcancer patients. Methods: Patient planning CT or previous day's CBCTimages are used as the prior images. The new CBCTimages are considered as a deformation of the prior images. The deformation field is solved by meeting the data fidelity constraint and minimizing the deformation energy of the field. The new CBCTimages are then obtained by deforming the prior images according to the deformation field. Data for ten lungcancer patients were tested for estimation using 57 projections acquired over 60° and 360° scan angles. The new CBCT reconstructed from fully sampled projections were used as the ground truth. Geometric accuracy of the estimation was evaluated using tumor volume percentage error. Dosimetric accuracy was evaluated by comparing the PTV dose distribution in each set of images. Results: The tumor volume percentage error was 13.3% and 4.3% in CBCT estimated using 57 projections over 60° and 360° scan angles, respectively. PTV min., mean and max. doses in estimated CBCT agree with those in true CBCT within 2% and 1% for 60° and 360° scan angles, respectively. The percentage volume of PTV covered by prescription dose in estimated CBCT agrees with that in true CBCT within 4% and 1% for 60° and 360° scan angles, respectively. The isodose lines in the estimated CBCTimages also match well with those in the true CBCTimages. Conclusions: The proposed method is able to provide accurate guidance for plan adaptation in ART treatment of lungcancer patients using 57 projections acquired over 360° scan angle. This implies a 12‐fold reduction in imagingdose relative to conventional CBCT for similar image quality for target delineation and dose calculation in ART.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.